(University of Texas M. D. Anderson Cancer Center) Researchers from the University of Texas M. D. Anderson Cancer Center have developed a new assessment tool to measure the severity of symptoms that can complicate stem cell transplantation. The tool assesses symptoms resulting from chronic graft-vs.-host disease (cGVHD), and was presented with supporting research at the 2010 Bone and Marrow Transplant Tandem Meeting.

Further information:

Article source

Related posts:

1. Costly tests may not help detect bladder cancer recurrence, M. D. Anderson study finds
2. New strategy develops 2 prototype drugs against cancer, retinal diseases
3. Most early-stage breast cancer patients may not need radiation after mastectomy
4. MicroRNA-TP53 circuit connected to chronic lymphocytic leukemia
5. Bone marrow cell transplants to benefit those with heart disease